Drug Safety Update Publishes September 2007 Guide For Doctors To Assess HRT Risks And Benefits
(Posted by Tom Lamb at DrugInjuryWatch.com)
The second issue of Drug Safety Update, an electronic bulletin (PDF file) published by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), was published on September 3, 2007. It includes some important side effects information for doctors who prescribe hormone-replacement therapy (HRT).
As described by Claire Tilstone, the Editor of Drug Safety Update:
We have prepared digested guide of current evidence for the associations between HRT and coronary heart disease; stroke; venous thromboembolism; and cancers of the breast, endometrium, or ovary. We hope that this updated information, including
revised risk estimates, will help healthcare professionals assess the risks and
benefits associated with HRT for individual women.
Of course, this advisory article from Volume 1, Issue 2 of Drug Safety Update will also be of interest to some of the women who use HRT drugs as well as others who follow the developing safety profile of HRT drugs.